Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VAISHALI | NSE
-3.88
-1.98%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
192.25
196.13
197.90
186.01
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs) including antibiotics anti-ulcer anti-inflammatory/analgesic/anti-pyretic anti-malarial cardiac anti-diabetic anti-cold/anti-allergic anti-diarrheal/anti-protozoal/anti-parasitic anti-viral anti-epileptic anti-asthmatic anti-fungal anti-platelet agent skeletal muscle relaxant and anti-helmintic drugs as well as excipients topical steroids corticosteroids and enzymes. The company also provides formulation products such as laxative anti-ulcer/enzyme anti-asthmatic anti-viral anti-psychotic vitamins and other formulations. In addition it offers veterinary pharmaceutical nutraceutical oncology herbal and surgical products. The company was founded in 1989 and is headquartered in Mumbai India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Microcap (<300M USD)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
50.3%1 month
55.4%3 months
50.9%6 months
50.9%333.23
-
5.17
0.31
0.17
61.48
2.70
-
12.35M
2.06B
24.59M
-
12.31
-2.10
34.70
1.73
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
28.90
Range1M
52.00
Range3M
64.70
Rel. volume
0.49
Price X volume
50.10M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Mangalam Drugs & Organics Limited | MANGALAM | Drug Manufacturers-Specialty & Generic | 127.32 | 2.02B | -6.02% | n/a | 72.53% |
Bal Pharma Limited | BALPHARMA | Drug Manufacturers-Specialty & Generic | 127.24 | 2.01B | -3.31% | 27.01 | 201.53% |
Krebs Biochemicals & Industries Limited | KREBSBIO | Drug Manufacturers-Specialty & Generic | 90.59 | 1.96B | -2.00% | n/a | -162.25% |
Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 79.14 | 1.89B | 658.33 | 30.17% | |
Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 66.39 | 1.86B | -3.31% | 34.02 | 23.61% |
Lasa Supergenerics Limited | LASA | Drug Manufacturers-Specialty & Generic | 27.12 | 1.36B | -4.57% | n/a | 22.84% |
Ind-Swift Limited | INDSWFTLTD | Drug Manufacturers-Specialty & Generic | 23.81 | 1.29B | -1.37% | 3.23 | -146.78% |
Biofil Chemicals and Pharmaceuticals Limited | BIOFILCHEM | Drug Manufacturers-Specialty & Generic | 77.68 | 1.26B | -7.23% | 197.64 | 2.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 166.42 | 1.85B | -3.27% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 61.48 | 23.29 | Expensive |
Ent. to Revenue | 2.70 | 12.02 | Cheaper |
PE Ratio | 333.23 | 47.84 | Expensive |
Price to Book | 5.17 | 6.55 | Cheaper |
Dividend Yield | - | 0.59 | - |
Std. Deviation (3M) | 50.88 | 40.95 | Riskier |
Debt to Equity | 0.31 | 0.34 | Par |
Debt to Assets | 0.17 | 0.17 | Par |
Market Cap | 2.06B | 286.13B | Emerging |